RaySearch Laboratories AB (STO:RAY-B), a Swedish provider of software for radiation therapy, announced on Tuesday that it has received an order for the product DrugLog from Polish company Medim.

This order is a result of Medim winning a tender from The Children's Memorial Health Institute in Warsaw, Poland.

DrugLog is RaySearch's cost-effective solution for quickly and efficiently verifying the identity and concentration of compounded injectable medications used, for example, in cancer treatment with cytostatic drugs (chemotherapy). DrugLog is used to detect errors in the preparation of drugs, which reduces the risk of medication errors. DrugLog combines cutting-edge software with well-established hardware for absorption spectroscopy.

The order includes DrugLog and support agreements for the second and third year.

"Medim is our first customer for DrugLog, which we acquired at the beginning of the year to complement our existing product offering," said Johan Löf, founder and CEO of RaySearch. "DrugLog represents a further step towards the vision of providing software support for all types of cancer treatments, including chemotherapy and surgery."